INSM Earnings

INSM reported its earnings on 2026-05-07, showcasing a revenue of 305.96M against an estimate of 308.10M, resulting in a -0.69% surprise. The EPS was -0.76, surpassing the expected -0.9 by 15.56%. The stock experienced a -23.41% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following INSM's earnings announcement on 2026-05-07, the stock price moved by -23.41% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, INSM's stock price tends to shift by an average of 2.83% in the 10 days leading up to earnings and 0.36% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate INSM's annual revenue to reach 254.25M, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between INSM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, INSM's stock price typically moves by 2.83% in the 10 days before its earnings and 0.36% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -1.00 and revenue of 254.25M.

The earnings call summary shows strong financial performance with impressive revenue guidance for BRINSUPRI and ARIKAYCE's continued growth. The Q&A section reveals confidence in sustained demand and strategic focus on expanding the patient base, despite some uncertainty in international markets. The company's robust cash position and pathway to profitability without raising additional capital further support a positive outlook. Despite some management evasiveness, the overall sentiment is positive, indicating a likely stock price increase in the near term.